Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.63 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.62 |
| ▸ | PPARG | P37231 | 4/20 | 0.56 |
| ▸ | PPARD | Q03181 | 4/20 | 0.56 |
| ▸ | PPARA | Q07869 | 4/20 | 0.56 |
| ▸ | TERT | O14746 | 3/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | FABP4 | P15090 | 2/20 | 0.56 |
| ▸ | F7 | P08709 | 2/20 | 0.56 |
| ▸ | F3 | P13726 | 2/20 | 0.56 |
| ▸ | GMNN | O75496 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL380888 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL258956 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL14798059 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL274867 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL15526298 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL2014792 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL1603841 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL1654500 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL17744969 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT | |
| SCHEMBL174463 | 1.00 | LMNA (0.63) | LMNATSHRNFKB1PMP22MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3488000-A1 | METHODS AND MATERIALS FOR BIOSYNTHESIZING MULTIFUNCTIONAL, MULTIVARIATE MOLECULES VIA CARBON CHAIN MODIFICATION | INVISTA Textiles (U.K.) Limited (GB) | 2019-05-29 | — | — | EP | claimed |
| WO-2018022633-A1 | METHODS AND MATERIALS FOR BIOSYNTHESIZING MULTIFUNCTIONAL, MULTIVARIATE MOLECULES VIA CARBON CHAIN MODIFICATION | INVISTA TEXTILES (U.K.) LIMITED (GB) | 2018-02-01 | — | — | WO | claimed |
| WO-2011124228-A1 | A BIOCIDAL POLYOLEFIN YARN WITH 3-12 FILAMENTS | VESTERGAARD FRANDSEN SA (CH) | 2011-10-13 | — | — | WO | claimed |
| WO-2011124227-A1 | BIOCIDAL ACID-ADJUSTED POLYMER WITH POLYPROPYLENE | VESTERGAARD FRANDSEN SA (CH) | 2011-10-13 | — | — | WO | claimed |
| EP-0057975-B1 | PROCESS FOR PRODUCING POLYCONDENSATES OF OMEGA-OXYPENTADECONOIC ACID | Takasago Perfumery Co., Ltd. (JP) | 1985-08-14 | — | — | EP | claimed |
| US-4419292-A | Process for producing polycondensates of ω-oxypentadecanoic acid | TAKASAGO PERFUMERY CO., LTD. (JP) | 1983-12-06 | — | — | US | claimed |
| EP-0057975-A1 | Process for producing polycondensates of omega-oxypentadeconoic acid | Takasago Perfumery Co., Ltd. (JP) | 1982-08-18 | — | — | EP | claimed |
| EP-4605368-A1 | NEW METHOD FOR THE OZONOLYTIC SYNTHESIS OF HIGH MELTING DICARBOXYLIC ACIDS AND OXO-ACIDS | P2 Science, Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| WO-2024112938-A1 | NEW METHOD FOR THE OZONOLYTIC SYNTHESIS OF HIGH MELTING DICARBOXYLIC ACIDS AND OXO-ACIDS | P2 SCIENCE, INC. (US) | 2024-05-30 | — | — | WO | disclosed |
| US-20230143604-A1 | QW DOSING OF GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-05-11 | — | — | US | disclosed |
| CN-108467861-B | Sequence for catalytically synthesizing linear alpha-olefin biocatalyst OleT-BM3R, preparation method and application thereof | 扬州大学 | 2021-10-22 | — | — | CN | disclosed |
| EP-3842061-A1 | STAPLED TRIAZOLE CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS | MERCK SHARP & DOHME CORP. (US) | 2021-06-30 | — | — | EP | disclosed |
| EP-3488000-A1 | METHODS AND MATERIALS FOR BIOSYNTHESIZING MULTIFUNCTIONAL, MULTIVARIATE MOLECULES VIA CARBON CHAIN MODIFICATION | INVISTA Textiles (U.K.) Limited (GB) | 2019-05-29 | — | — | EP | disclosed |
| EP-2070919-A1 | SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION | Hykes Laboratories LLC (JP) | 2009-06-17 | — | — | EP | disclosed |
| EP-0057975-B1 | PROCESS FOR PRODUCING POLYCONDENSATES OF OMEGA-OXYPENTADECONOIC ACID | Takasago Perfumery Co., Ltd. (JP) | 1985-08-14 | — | — | EP | disclosed |
| US-4419292-A | Process for producing polycondensates of ω-oxypentadecanoic acid | TAKASAGO PERFUMERY CO., LTD. (JP) | 1983-12-06 | — | — | US | disclosed |
| US-4419292-A | Process for producing polycondensates of ω-oxypentadecanoic acid | TAKASAGO PERFUMERY CO., LTD. (JP) | 1983-12-06 | — | — | US | disclosed |
| US-4419292-A | Process for producing polycondensates of ω-oxypentadecanoic acid | TAKASAGO PERFUMERY CO., LTD. (JP) | 1983-12-06 | — | — | US | disclosed |
| EP-0057975-A1 | Process for producing polycondensates of omega-oxypentadeconoic acid | Takasago Perfumery Co., Ltd. (JP) | 1982-08-18 | — | — | EP | disclosed |
| EP-0057975-A1 | Process for producing polycondensates of omega-oxypentadeconoic acid | Takasago Perfumery Co., Ltd. (JP) | 1982-08-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143604-A1 | QW DOSING OF GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF | GIPR, GLP1R, GRPR | LMNA 4542/4885TSHR 84/4885NFKB1 4093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.